中国骨质疏松杂志2024,Vol.30Issue(5) :775-780.DOI:10.3969/j.issn.1006-7108.2024.05.027

SARMs在肌少症治疗中的机制与进展

Therapeutic prospects of SARMs in sarcopenia

袁瑾 方玲娜 李翀
中国骨质疏松杂志2024,Vol.30Issue(5) :775-780.DOI:10.3969/j.issn.1006-7108.2024.05.027

SARMs在肌少症治疗中的机制与进展

Therapeutic prospects of SARMs in sarcopenia

袁瑾 1方玲娜 2李翀2
扫码查看

作者信息

  • 1. 江苏省江苏大学,江苏镇江 212000
  • 2. 江苏大学附属昆山医院,江苏苏州 215300
  • 折叠

摘要

肌少症(sarcopenia)是当前一类严重影响老年人的日常行为能力和生活质量的疾病.因其发病率逐年增多,近些年各专家对于肌少症的研究也逐步深入.肌少症的治疗方法和治疗药物的研究备受关注,其中,选择性雄激素受体调节剂(selective androgen receptor modulators,SARMs)是一大研究热点,本篇综述的主要目的是探讨SARMs在肌少症的发生发展中的作用机制、研究和临床进展,以便于未来能更快更好地应用于临床治疗.

Abstract

Sarcopenia is a current group of diseases that seriously affect the daily behavior ability and quality of life of the elderly.Because its incidence has increased year by year,the research of various experts on sarcopenia has gradually deepened in recent years.The research on the treatment method and therapeutic drugs of sarcopenia has attracted much attention,among which Selective Androgen Receptor Modulators(SARMs)is a major research hotspot,the main purpose of this review is to explore the mechanism of action of SARMs in the occurrence and development of sarcopenia,research and clinical progress,so that it can be applied to clinical treatment faster and better in the future.

关键词

肌少症/选择性雄激素受体调节剂/雄激素/雄激素受体

Key words

sarcopenia/therapeutic drugs/SARMs/androgen/androgen receptors

引用本文复制引用

基金项目

昆山市骨质疏松性骨质防治重点实验室项目(KZ2023005)

江苏省卫生健康委医学科研项目(2021)(Z2021026)

昆山市科技专项(2021)(KSZ2155)

出版年

2024
中国骨质疏松杂志
中国老年学和老年医学学会

中国骨质疏松杂志

CSTPCDCSCD北大核心
影响因子:1.439
ISSN:1006-7108
参考文献量4
段落导航相关论文